Clinical Trial Update: Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating camrelizumab in combination with neoadjuvant chemotherapy for osteosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Osteosarcoma | Phase 2 | Status: UNKNOWN